These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10372254)

  • 1. GAD antibodies in elderly men in different categories of glucose tolerance.
    Ylihärsilä H; Tuomilehto J; Mackay IR; Zimmet P; Tuomilehto-Wolf E; Rowley MJ; Nissinen A
    Diabetes Care; 1999 Jun; 22(6):996-7. PubMed ID: 10372254
    [No Abstract]   [Full Text] [Related]  

  • 2. Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study.
    Ruige JB; Batstra MR; Aanstoot HJ; Bouter LM; Bruining GJ; De Neeling JN; Heine RJ
    Diabetes Care; 1997 Jul; 20(7):1108-10. PubMed ID: 9203445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of the 65-kilodalton isoform of glutamic acid decarboxylase autoantibodies by glucose tolerance status in elderly patients from the cardiovascular health study.
    Barinas-Mitchell E; Kuller LH; Pietropaolo S; Zhang YJ; Henderson T; Pietropaolo M
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2871-7. PubMed ID: 16720660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the oral glucose tolerance test obsolete?
    Drash AL
    Diabetes Care; 1995 Jul; 18(7):1072-3. PubMed ID: 7555544
    [No Abstract]   [Full Text] [Related]  

  • 5. The possible role of autoimmunity in the pathogenesis of diabetes in B-thalassemia major.
    Monge L; Pinach S; Caramellino L; Bertero MT; Dall'omo A; Carta Q
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):149-54. PubMed ID: 11353881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent autoimmune diabetes and limbic encephalitis with antibodies against glutamic acid decarboxylase.
    Popkirov S; Sebastian S; Ismail FS; Wellmer J
    J Diabetes; 2018 Apr; 10(4):338-340. PubMed ID: 29154389
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of GAD positivity in elderly patients with diabetes.
    Meneilly GS; Tildesley H; Elliott T; Palmer JP; Juneja R
    Diabet Med; 2000 Mar; 17(3):247-8. PubMed ID: 10784232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoantibodies to glutamate decarboxylase in children with newly detected insulin-dependent diabetes mellitus].
    Trofimenko EV; Zlobina EV; Lebedev NV; Martynova MI; Piliutik VF; Shchegol'kova TS; Zlobina EN; Dedov II
    Probl Endokrinol (Mosk); 1994; 40(2):18-21. PubMed ID: 8197083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
    Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
    Diabetes Care; 1999 Jan; 22(1):175-6. PubMed ID: 10333923
    [No Abstract]   [Full Text] [Related]  

  • 11. Glutamic acid decarboxylase antibodies and diabetes complications. Assay reliability and validity.
    Lernmark A
    Diabetes Care; 1995 Feb; 18(2):269-71. PubMed ID: 7729309
    [No Abstract]   [Full Text] [Related]  

  • 12. GAD65 antibodies among Greenland Inuit and its relation to glucose intolerance.
    Pedersen ML; Bjerregaard P; Jørgensen ME
    Acta Diabetol; 2014 Aug; 51(4):641-6. PubMed ID: 24549416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of islet autoantibodies in patients with gestational diabetes mellitus.
    Dozio N; Beretta A; Belloni C; Castiglioni M; Rosa S; Bosi E; Bonifacio E
    Diabetes Care; 1997 Jan; 20(1):81-3. PubMed ID: 9028700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.
    Rodriguez BL; Curb JD; Burchfiel CM; Huang B; Sharp DS; Lu GY; Fujimoto W; Yano K
    Diabetes Care; 1996 Jun; 19(6):587-90. PubMed ID: 8725856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A step backward--or is it forward?
    Genuth S; Kahn R
    Diabetes Care; 2008 Jun; 31(6):1093-6. PubMed ID: 18509143
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts.
    Qiao Q; Nakagami T; Tuomilehto J; Borch-Johnsen K; Balkau B; Iwamoto Y; Tajima N; ;
    Diabetologia; 2000 Dec; 43(12):1470-5. PubMed ID: 11151755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
    Lundberg TP; Højlund K; Snogdal LS; Jensen DM
    Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of GAD autoantibodies in Brazilian women with previous gestational diabetes.
    Ferraz TB; Motta RS; Capibaribe DM; Ferraz CL; Chacra AR; Forti AC; Dib SA
    Diabetes Res Clin Pract; 2007 Oct; 78(1):141-2. PubMed ID: 17367891
    [No Abstract]   [Full Text] [Related]  

  • 19. Fasting glucose and increasing age.
    Dzien A; Dzien-Bischinger C; Lechleitner M
    Diabetes Obes Metab; 2001 Aug; 3(4):297-8. PubMed ID: 11520311
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.